"Studia Pneumologica et Phthiseologica" . . "11140" . "3"^^ . "P(NR9087)" . . "Auto\u0159i vyhodnotili \u00FA\u010Dinnost podle l\u00E9\u010Debn\u00E9 odpov\u011Bdi, \u010Dasu do progrese a celkov\u00E9ho p\u0159e\u017Eit\u00ED u l\u00E9\u010Dby gefitinibem u nemocn\u00FDch s NSCLC. Prok\u00E1zali srovnatelnou \u00FA\u010Dinnost i bezpe\u010Dnost s v\u00FDsledky zahrani\u010Dn\u00EDch autor\u016F." . "1"^^ . "2" . "350492" . . . "8"^^ . . . "V\u00FDsledky klinick\u00E9ho hodnocen\u00ED \u00FA\u010Dinnosti a toxicity gefitinibu v r\u00E1mci programu \u010Dasn\u00E9ho p\u0159\u00EDstupu u nemalobun\u011Bn\u010D\u00E9ho karcinomu plic v \u010Cesk\u00E9 republice"@cs . . "[0883B672284B]" . . . . "RIV/00216208:11140/09:00202199!RIV10-MZ0-11140___" . . "69" . . "1213-810X" . "V\u00FDsledky klinick\u00E9ho hodnocen\u00ED \u00FA\u010Dinnosti a toxicity gefitinibu v r\u00E1mci programu \u010Dasn\u00E9ho p\u0159\u00EDstupu u nemalobun\u011Bn\u010D\u00E9ho karcinomu plic v \u010Cesk\u00E9 republice" . . . . . "Pe\u0161ek, Milo\u0161" . "Sk\u0159i\u010Dkov\u00E1, Jana" . "V\u00FDsledky klinick\u00E9ho hodnocen\u00ED \u00FA\u010Dinnosti a toxicity gefitinibu v r\u00E1mci programu \u010Dasn\u00E9ho p\u0159\u00EDstupu u nemalobun\u011Bn\u010D\u00E9ho karcinomu plic v \u010Cesk\u00E9 republice" . . "CZ - \u010Cesk\u00E1 republika" . "Authors evaluated therapeutic responses, time to progression and overal survival of NSCLC patients treated by gefitinib in Czech patients. Comparable efficacy and tolerance of therapy was found if compared with results of other authors."@en . "Kolek, V\u00EDt\u011Bzslav" . . "RIV/00216208:11140/09:00202199" . . . "Results; clinical; evaluation; gefitinib; therapeutic; activity; toxicity; early; access; programme; NSCLC; treatment; Czech; Republic"@en . "Results of clinical evaluation of gefitinib therapeutic activity and toxicity in early access programme of NSCLC treatment in Czech Republic"@en . . . "Results of clinical evaluation of gefitinib therapeutic activity and toxicity in early access programme of NSCLC treatment in Czech Republic"@en . . "V\u00FDsledky klinick\u00E9ho hodnocen\u00ED \u00FA\u010Dinnosti a toxicity gefitinibu v r\u00E1mci programu \u010Dasn\u00E9ho p\u0159\u00EDstupu u nemalobun\u011Bn\u010D\u00E9ho karcinomu plic v \u010Cesk\u00E9 republice"@cs . . . "Auto\u0159i vyhodnotili \u00FA\u010Dinnost podle l\u00E9\u010Debn\u00E9 odpov\u011Bdi, \u010Dasu do progrese a celkov\u00E9ho p\u0159e\u017Eit\u00ED u l\u00E9\u010Dby gefitinibem u nemocn\u00FDch s NSCLC. Prok\u00E1zali srovnatelnou \u00FA\u010Dinnost i bezpe\u010Dnost s v\u00FDsledky zahrani\u010Dn\u00EDch autor\u016F."@cs . .